Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-26 @ 5:55 AM
Study NCT ID:
NCT02572492
Status:
UNKNOWN
Last Update Posted:
2018-08-17
First Post:
2015-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support
Sponsor:
Henrik Gregersen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2018-04-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04
Completion Date Type:
ESTIMATED
First Submit Date:
2015-10-06
First Submit QC Date:
None
Study First Post Date:
2015-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-16
Last Update Post Date:
2018-08-17
Last Update Post Date Type:
ACTUAL